ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 98 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -32.6% | 41,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $301 | +171.2% | 41,000 | +68.7% | 0.00% | – |
| Q1 2023 | $111 | -60.1% | 24,300 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $278 | -99.9% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $233,000 | +18.3% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $197,000 | -53.2% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $421,000 | -13.2% | 24,300 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $485,000 | -69.2% | 22,100 | +2.8% | 0.00% | -75.0% |
| Q3 2021 | $1,577,000 | +184.1% | 21,500 | +104.8% | 0.00% | +100.0% |
| Q2 2021 | $555,000 | -22.6% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $717,000 | -19.1% | 10,500 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $886,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |